Sulphasalazine therapy in chronic uveitis of children with chronic arthritis

Jing Long Huang*, Iou Jih Hung, Kue Hsiung Hsieh

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

15 Scopus citations


Four children with chronic arthritis (3 juvenile rheumatoid arthritis and 1 juvenile ankylosing spondylitis) and poorly controlled chronic uveitis, were given sulphasalazine (SASP) therapy for a mean period of 3.3 years. Three patients showed an excellent response, as evidenced by a reduction of inflammatory cells in the anterior chamber of the eyes and improvement of visual acuity. The response occurred after a mean of 7.7 weeks. These data suggested SASP therapy may have a role in the treatment of chronic anterior uveitis in children with chronic arthritis.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalAsian Pacific Journal of Allergy and Immunology
Issue number2
StatePublished - 06 1997
Externally publishedYes


Dive into the research topics of 'Sulphasalazine therapy in chronic uveitis of children with chronic arthritis'. Together they form a unique fingerprint.

Cite this